Deutsche Bank raised the firm’s price target on HCA Healthcare to $330 from $280 and keeps a Buy rating on the shares. The company reported a “healthy” Q4 beat and 2024 outlook that drove upside to high expectations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HCA:
